药品详细
Alizapride(阿立必利)
化学结构式图
中文名
阿立必利
英文名
Alizapride
分子式
C16H21N5O2
化学名
6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide
分子量
Average: 315.3702
Monoisotopic: 315.169524941
Monoisotopic: 315.169524941
CAS号
59338-93-1
ATC分类
A03F 未知
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍
Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.
生产厂家
封装厂家
参考
Synthesis Reference | Not Available |
General Reference |
|
剂型
规格
化合物类型
Type | small molecule |
Classes |
|
Substructures |
|
适应症
药理
Indication | Alizapride is used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. |
Pharmacodynamics | Alizapride is a dopamine antagonist. |
Mechanism of action | The anti-emetic action of Alizapride is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone (CTZ) in the central nervous system (CNS)—this action prevents nausea and vomiting triggered by most stimuli. Structurally similar to metoclopramide and, therefore, shares similar other atributres related to emesis and prokinetics. |
Absorption | Not Available |
Volume of distribution | Not Available |
Protein binding | Not Available |
Metabolism |
Not Available
|
Route of elimination | renal |
Half life | 3 hours |
Clearance | Not Available |
Toxicity | Not Available |
Affected organisms | Not Available |
Pathways | Not Available |
理化性质
Properties | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | ||||||||||||||||||||||||||||||||||||||||||
Experimental Properties |
|
||||||||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
药物相互作用
食物相互作用
Not Available